In last trading session, Bone Biologics Corp (NASDAQ:BBLG) saw 2.15 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $2.02 trading at $0.21 or 11.60% at ring of the bell on the day assigns it a market valuation of $1.07M. That closing price of BBLG’s stock is at a discount of -422.77% from its 52-week high price of $10.56 and is indicating a premium of 60.4% from its 52-week low price of $0.80. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.31 million shares which gives us an average trading volume of 4.92 million if we extend that period to 3-months.
Bone Biologics Corp (NASDAQ:BBLG) trade information
Upright in the green during last session for gaining 11.60%, in the last five days BBLG remained trading in the green while hitting it’s week-highest on Friday, 10/18/24 when the stock touched $2.02 price level, adding 12.17% to its value on the day. Bone Biologics Corp’s shares saw a change of -55.31% in year-to-date performance and have moved 20.96% in past 5-day. Bone Biologics Corp (NASDAQ:BBLG) showed a performance of 10.99% in past 30-days. Number of shares sold short was 0.35 million shares which calculate 0.04 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bone Biologics Corp (BBLG) estimates and forecasts
Statistics highlight that Bone Biologics Corp is scoring comparatively higher than the scores of other players of the relevant industry. The company added 25.47% of value to its shares in past 6 months, showing an annual growth rate of 90.68% while that of industry is 17.20. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 42.24% during past 5 years.
Bone Biologics Corp (NASDAQ:BBLG)’s Major holders
Insiders are in possession of 5.21% of company’s total shares while institution are holding 3.23 percent of that, with stock having share float percentage of 3.41%. Investors also watch the number of corporate investors in a company very closely, which is 3.23% institutions for Bone Biologics Corp that are currently holding shares of the company. UBS GROUP AG is the top institutional holder at BBLG for having 33707.0 shares of worth $41123.0. And as of 2024-06-30, it was holding 5.1 of the company’s outstanding shares.
The second largest institutional holder is HRT FINANCIAL LP, which was holding about 17519.0 shares on 2024-06-30. The number of shares represents firm’s hold over 2.6507 of outstanding shares, having a total worth of $21000.0.
